HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surender Singh Jadav Selected Research

Neoplasms (Cancer)

10/2023Synthesis of aminomethyl linked (+)-usnic acid derivatives via the Mannich reaction and evaluation of their biological activities.
9/2023AMPK targets a proto-oncogene TPD52 (isoform 3) expression and its interaction with LKB1 suppress AMPK-GSK3β signaling axis in prostate cancer.
6/2023Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders.
1/2023Synthesis of novel thiazoles bearing lupeol derivatives as potent anticancer and anti-inflammatory agents.
3/2019Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy.
1/2019Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
1/2013Synthesis, characterisation, and in vitro anticancer activity of curcumin analogues bearing pyrazole/pyrimidine ring targeting EGFR tyrosine kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Surender Singh Jadav Research Topics

Disease

7Neoplasms (Cancer)
10/2023 - 01/2013
1Prostatic Neoplasms (Prostate Cancer)
09/2023
1Virus Diseases (Viral Diseases)
01/2023
1Thrombocytopenia (Thrombopenia)
01/2023
1Dengue (Dengue Fever)
01/2023
1Lung Neoplasms (Lung Cancer)
09/2022
1Colorectal Neoplasms (Colorectal Cancer)
02/2021
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
07/2020
1Infections
11/2017
1Edema (Dropsy)
01/2017
1Ebola Hemorrhagic Fever
01/2015
1Tuberculosis (Tuberculoses)
01/2015
1Extensively Drug-Resistant Tuberculosis
01/2015

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
09/2023 - 02/2021
2Phosphotransferases (Kinase)IBA
09/2023 - 06/2023
2LigandsIBA
01/2023 - 01/2015
2VaccinesIBA
11/2017 - 01/2015
1AntioxidantsIBA
10/2023
1AminesIBA
10/2023
1usnic acidIBA
10/2023
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
09/2023
1Protein Isoforms (Isoforms)IBA
09/2023
1OxazolesIBA
01/2023
1lupeolIBA
01/2023
1ThiazolesIBA
01/2023
1Antiviral Agents (Antivirals)IBA
01/2023
1HydrazonesIBA
01/2023
1pyrazoleIBA
01/2023
1eltrombopagFDA Link
01/2023
1Antineoplastic Agents (Antineoplastics)IBA
09/2022
1Carrier Proteins (Binding Protein)IBA
02/2021
1CateninsIBA
02/2021
1emopamil (levemopamil)IBA
02/2021
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
07/2020
1TubulinIBA
03/2019
1Cyclin-Dependent Kinase 4IBA
03/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1CarrageenanIBA
01/2017
1Antitubercular AgentsIBA
01/2015
1CurcuminIBA
01/2013

Therapy/Procedure

2Therapeutics
01/2023 - 01/2013
1Drug Therapy (Chemotherapy)
01/2015